Safety evaluation on concomitant immunization with inactivated poliomyelitis vaccine produced from Sabin strains and other vaccines (from 2015 to 2020)

Safety evaluation on concomitant immunization with inactivated poliomyelitis vaccine produced from Sabin strains and other vaccines (from 2015 to 2020)

Objective To evaluate the safety of concomitantly administering inactivated poliomyelitis vaccine produced from Sabin strains (sIPVs) with other vaccines. Methods A descriptive analysis was carried out on adverse events following immunization (AEFI) based on the administration of sIPV alone or conco...

Full description

Bibliographic Details
Main Authors:	Yan Deng, Li Yi, Ying Li, Zhimei Zhao, Zhilei Zhong, Haoyu Shi, Jiarong Li, Yan Liang, Jingsi Yang
Format:	Article
Language:	English
Published:	Taylor & Francis Group 2022-01-01
Series:	Human Vaccines & Immunotherapeutics
Subjects:	inactivated poliomyelitis vaccine made from the sabin strain adverse events following immunization concomitant immunization safety medical dictionary for regulatory activities
Online Access:	http://dx.doi.org/10.1080/21645515.2022.2041944

Similar Items

A Comparison with Adverse Events Following Immunization Associated with Sabin-Strains and Salk-Strains Inactivated Polio Vaccines in Zhejiang Province, China
by: Huakun Lv, et al.
Published: (2022-02-01)

Effect of maternal antibody on the infant immune response to inactivated poliovirus vaccines made from Sabin strains
by: Rong Tang, et al.
Published: (2019-05-01)

Immune Persistence following Primary Immunization and the Immunogenicity and Safety of a Booster Dose of a Multidose Sabin Strain-Based Inactivated Polio Vaccine in Infants Aged 18 Months
by: Guangwei Feng, et al.
Published: (2024-01-01)

Potency of the Sabin inactivated poliovirus vaccine (sIPV) after exposure to freezing temperatures in cold chains
by: Wei Cai, et al.
Published: (2020-08-01)

A phase 3 randomized, open-label study evaluating the immunogenicity and safety of concomitant and staggered administration of a live, pentavalent rotavirus vaccine and an inactivated poliomyelitis vaccine in healthy infants in China
by: Shaomin Chen, et al.
Published: (2024-12-01)

Quantitative Analysis of the Instant and Persistent Inhibition Effects of Maternal Poliovirus Antibodies on the Immune Response in a Phase IV Trial of a Sabin Strain-Based Inactivated Poliovirus Vaccine
by: Qiongzhou Yin, et al.
Published: (2024-02-01)

Surveillance of immunity acquired from poliovirus immunization including vaccination with the Sabin strain-derived inactivated vaccine
by: Chiemi Hotta, et al.
Published: (2019-05-01)

Cost-effectiveness of various immunization schedules with inactivated Sabin strain polio vaccine in Hangzhou, China
by: Yuyang Xu, et al.
Published: (2022-09-01)

Immunogenicity and Safety of Inactivated Sabin-Strain Polio Vaccine “PoliovacSin”: Clinical Trials Phase I and II
by: Anastasia Piniaeva, et al.
Published: (2021-05-01)

A phase Ⅱ, randomized, controlled trial to evaluate the safety and immunogenicity of a Sabin strain-based inactivated polio vaccine
by: Rong Tang, et al.
Published: (2020-11-01)

Preventive Vaccination against Poliomyelitis: Modern View
by: E. V. Karpova, et al.
Published: (2018-12-01)

Vaccine-associated paralytic poliomyelitis in Russian Federation during the period of changes in vaccination schedule (2006-2013 y.y.)
by: O. E. Ivanova, et al.
Published: (2016-02-01)

A developing country perspective on vaccine-associated paralytic poliomyelitis
by: John T. Jacob
Published: (2004-01-01)

Post-marketing surveillance study to assess the safety and tolerability of an Inactivated Poliomyelitis Vaccine in Indian children
by: Hitt Sharma, et al.
Published: (2017-11-01)

Application of Ion Exchange Chromatography in the Development of Technology to Obtain Inactivated Poliovirus Vaccine
by: A. N. Piniaeva, et al.
Published: (2022-11-01)

Safety and immunogenicity of a new Sabin inactivated poliovirus vaccine candidate produced on the PER.C6® cell-line: a phase 1 randomized controlled trial in adults
by: Isabel Leroux-Roels, et al.
Published: (2021-05-01)

Safety, Immunogenicity and Lot-to-Lot Consistency of Sabin-Strain Inactivated Poliovirus Vaccine in 2-Month-Old Infants: A Double-Blind, Randomized Phase III Trial
by: Yan Zheng, et al.
Published: (2022-02-01)

Analysis of the dose-sparing effect of adjuvanted Sabin-inactivated poliovirus vaccine (sIPV)
by: Zhuofan Li, et al.
Published: (2018-08-01)

A phase 2 study of a combined diphtheria-tetanus-acellular pertussis vaccine with a Sabin-derived inactivated poliovirus vaccine in children
by: Takashi Nakano, et al.
Published: (2018-12-01)

In-Vitro Inactivation of Sabin-Polioviruses for Development of Safe and Effective Polio Vaccine
by: Asmaa A. Abd-Elghaffar, et al.
Published: (2020-10-01)

Immune persistence of an inactivated poliovirus vaccine derived from the Sabin strain: a 10-year follow-up of a phase 3 studyResearch in context
by: Lei Ma, et al.
Published: (2023-10-01)

Safety, immunogenicity, and lot-to-lot consistency of a multidose Sabin strain-based inactivated polio vaccine: a phase III, randomized, blinded, positive-control clinical trial in infants aged 2 months
by: Guangwei Feng, et al.
Published: (2023-05-01)

Safety and immunogenicity of 3 formulations of a Sabin inactivated poliovirus vaccine produced on the PER.C6® cell line: A phase 2, double-blind, randomized, controlled study in infants vaccinated at 6, 10 and 14 weeks of age
by: Anna Lisa Ong-Lim, et al.
Published: (2022-11-01)

Immunogenicity and safety evaluation of bivalent types 1 and 3 oral poliovirus vaccine by comparing different poliomyelitis vaccination schedules in China: A randomized controlled non-inferiority clinical trial
by: Jingjun Qiu, et al.
Published: (2017-06-01)

Collective immunity against poliomyelitis among the population of several regions of Russia
by: V. B. Seybil, et al.
Published: (2015-08-01)

The state of specific immunity of population of the Republic of Tajikistan to measles, rubella, poliomyelitis viruses
by: Olga V. Tsvirkun, et al.
Published: (2023-07-01)

Sabin-related poliovirus vaccine strains isolated from transverse myelitis cases in Brazil
by: F. Friedrich, et al.
Published: (1995-12-01)

Case of Poliomyelitis Caused by Significantly Diverged Derivative of the Poliovirus Type 3 Vaccine Sabin Strain Circulating in the Orphanage
by: Ekaterina A. Korotkova, et al.
Published: (2020-09-01)

Surveillance of adverse events following the introduction of inactivated poliovirus vaccine made from Sabin strains (sIPV) to the Chinese EPI and a comparison with adverse events following inactivated poliovirus vaccine made from wild strains (wIPV) in Jiangsu, China
by: Guodong Kang, et al.
Published: (2021-08-01)

Importance of virological surveillance after migrants from polio high-risk territories for poliomyelitis monitoring in the Russian Federation
by: Olga I. Kanaeva, et al.
Published: (2024-12-01)

IMMUNOPROPHYLAXY OF POLYOMYELITIS: FROM THE FIRST INACTIVE TO THE LAST PERORAL VACCINE, OR HOW CLOSE IS THE «END OF THE GAME»?
by: O. A. Rychkova, et al.
Published: (2018-02-01)

Measures counteracting 2016 spread of vaccine-derived poliomyelitis virus type 2 in Russian Federation
by: A. Yu. Popova, et al.
Published: (2020-04-01)

Poliomyelitis in modern conditions: achievements and prospects
by: O. E. Ivanova
Published: (2018-07-01)

Advax-CpG Adjuvant Provides Antigen Dose-Sparing and Enhanced Immunogenicity for Inactivated Poliomyelitis Virus Vaccines
by: Yoshikazu Honda-Okubo, et al.
Published: (2021-04-01)

Eradication of poliomyelitis in countries affected by conflict
by: R.H. Tangermann, et al.
Published: (2000-03-01)

Immunogenicity and safety of concomitant administration of recombinant COVID-19 vaccine and quadrivalent inactivated influenza vaccine in Chinese adults: An open-label, randomized, controlled trial
by: Tao Huang, et al.
Published: (2024-12-01)

Stopping poliovirus vaccination after eradication: issues and challenges
by: D.J. Wood, et al.

Promising opportunities to improve polio vaccines
by: E. E. Evreinova, et al.
Published: (2022-07-01)

The Immunogenicity of Monovalent Oral Poliovirus Vaccine Type 1 (mOPV1) and Inactivated Poliovirus Vaccine (IPV) in the EPI Schedule of India
by: Lalitendu Mohanty, et al.
Published: (2024-04-01)

Religious Opposition to Polio Vaccination
by: Haider J. Warraich
Published: (2009-06-01)